| Gene symbol | IFNA2 | Synonyms | IFN-alpha-2, IFN-alphaA, IFNA, IFNA2B, leIF A | Type of gene | protein-coding | |
| Chromosome | 9 | Map location | 9p21.3 | dbXrefs | Entrez:3440 MIM:147562 HGNC:HGNC:5423 Ensembl:ENSG00000188379 AllianceGenome:HGNC:5423 | |
| Description | interferon alpha 2 | |||||
| GTO ID | GTC2070 |
| Trial ID | NCT03875495 |
| Disease | Multiple Myeloma |
| Altered gene | IFNA2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Temferon |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | A Phase I/II Dose Escalation Study Evaluating Safety and Activity of Autologous CD34+-Enriched Hematopoietic Progenitor Cells Genetically Modified With a Lentiviral Vector Encoding for the Human Interferon-ɑ2 Gene in Multiple Myeloma Patients With Early Relapse After Intensive Front Line Therapy |
| Year | 2019 |
| Country | Italy |
| Company sponsor | Genenta Science |
| Other ID(s) | TEM-MM-101 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||